Patient-perceived barriers to antiretroviral adherence
Associations with race
Bibliographic Data
| ID | 19442913 |
|---|---|
| Authors | T F Ferguson (University of Alabama), Kenneth Stewart (0000-0001-9768-0417, AIDS United), K E Stewart (b Division of Preventive Medicine, Department of Medicine , UAB), Ellen Funkhouser (0000-0002-9689-6491, Alabama Department of Public Health), Jerry M Tolson (Wellcome Library), J Tolson (d Glaxo-Wellcome, Inc , USA), Andrew O Westfall (0000-0002-0468-4695, Comprehensive Blood & Cancer Center), Michael S Saag (0000-0002-8866-1043, AIDS United) |
| Year | 2002 |
| Volume | 14 |
| Issue | 5 |
| Pages | 607-617 |
| Publication date | 2002-10-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | AIDS Care (JOURNAL) |
| Journal identifiers | ISSN: 0954-0121 • E-ISSN: 1360-0451 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/0954012021000005434 |
| PMID | 12419110 |
| OpenAlex | W1983769732 |
| Language | EN |
| Citations received | 18 |
| References cited | 26 |
New antiretroviral (ARV) regimens require strict adherence if optimal suppression of HIV is to be maintained. This study is a theory-based examination of racial differences in patient-perceived barriers and reported ARV adherence. Participants (N=149) completed the Patient Medication Adherence Questionnaire (PMAQ), measuring adherence and perceived barriers to adherence. Adherence was defined as a self-report of 100% adherence in the past four weeks. Odds ratios were calculated to determine the relation of reported barriers to adherence for race and gender groups, and for the sample overall. For every ten-point increase in barrier score, there was an 86% increased risk of being non-adherent (OR=1.86; 95% CI: 1.19, 2.91). Adherence was not different between racial and gender groups, nor was total barrier score. However, individual barriers were differentially endorsed across groups. Rather than relying on demographic predictors, which may be only an indirect marker of adherence, evaluations of adherence should examine the psychological and social barriers to positive adherence outcomes in individual patients. Our findings support the use of theory-based behavioural interventions that address perceived barriers to adherence and other health promotion activities
Family medicine · Medication adherence · Psychiatry · Psychological intervention · Adolescent Sexual and Reproductive Health · Clinical Psychology · HIV/AIDS Research and Interventions · LGBTQ Health, Identity, and Policy · Medicine · Internal Medicine
Adherence to antiretroviral therapy among HIV-infected children attending a donor-funded clinic at a tertiary hospital in Nigeria
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America
Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection
Understanding Structural Barriers to Accessing HIV Testing and Prevention Services Among Black Men Who Have Sex with Men (BMSM) in the United States
Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users
Appreciating Reasons for Nonadherence in Women
Temporal Aspects of Adherence to HIV Pre-Exposure Prophylaxis (PrEP)
Factors affecting first-month adherence to antiretroviral therapy amongHIV-positive adults in South Africa
Lipodystrophy Severity Does Not Contribute to Haart Nonadherence
Methadone Maintenance Therapy Decreases the Rate of Antiretroviral Therapy Discontinuation Among HIV-Positive Illicit Drug Users
Determinants of Optimal Adherence Over Time to Antiretroviral Therapy Amongst HIV Positive Adults in South Africa
Changes in Attitudes Toward Antiviral Medication
Associations among correlates of schedule adherence to antiretroviral therapy (ART)
Prediction of adherence to antiretroviral therapy
Cross-sectional evaluation of perceived health care provider engagement, self-efficacy, and ART adherence in people living with HIV/Aids
Problems taking pills
Reasons for ART non-adherence in the Deep South
Time, self and the medication day
The Health Belief Model and Sick Role Behavior
Zidovudine adherence among individuals with HIV infection
Acceptance of zidovudine (AZT) in early HIV disease
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus
The effect of patient race and socio-economic status on physicians' perceptions of patients
Determinants of subject compliance within an experimental anti-HIV drug protocol
| Unique citing works | 18 |
|---|---|
| Citations per year | 0,86 |
| Citation span | 2005 - 2025 (21) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 17 |